1. Cell Rep. 2018 Oct 23;25(4):988-1001. doi: 10.1016/j.celrep.2018.09.067.

KMT2B Is Selectively Required for Neuronal Transdifferentiation, and Its Loss 
Exposes Dystonia Candidate Genes.

Barbagiovanni G(1), Germain PL(1), Zech M(2), Atashpaz S(1), Lo Riso P(1), 
D'Antonio-Chronowska A(1), Tenderini E(1), Caiazzo M(3), Boesch S(4), Jech R(5), 
Haslinger B(6), Broccoli V(7), Stewart AF(8), Winkelmann J(9), Testa G(10).

Author information:
(1)Department of Experimental Oncology, IEO, European Institute of Oncology 
IRCCS, 20139 Milan, Italy.
(2)Institut für Neurogenomik, Helmholtz Zentrum München, 85764 Munich, Germany; 
Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar, Technische 
Universität München, 81675 Munich, Germany.
(3)San Raffaele Scientific Institute, 20132 Milan, Italy.
(4)Department of Neurology, Medical University Innsbruck, 6020 Innsbruck, 
Austria.
(5)Department of Neurology and Center of Clinical Neuroscience, First Faculty of 
Medicine, Charles University and General Faculty Hospital, 12821 Prague, Czech 
Republic.
(6)Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar, Technische 
Universität München, 81675 Munich, Germany.
(7)San Raffaele Scientific Institute, 20132 Milan, Italy; National Research 
Council (CNR), Institute of Neuroscience, 20129 Milan, Italy.
(8)Genomics, Biotechnology Center, Center for Molecular and Cellular 
Bioengineering, Technische Universität Dresden, 01069 Dresden, Germany.
(9)Institut für Neurogenomik, Helmholtz Zentrum München, 85764 Munich, Germany; 
Lehrstuhl für Neurogenetik und Institut für Humangenetik, Technische Universität 
München, 81675 Munich, Germany; Munich Cluster for Systems Neurology, SyNergy, 
81829 Munich, Germany.
(10)Department of Experimental Oncology, IEO, European Institute of Oncology 
IRCCS, 20139 Milan, Italy; Department of Oncology and Hemato-Oncology, 
University of Milan, 20122 Milan, Italy. Electronic address: 
giuseppe.testa@ieo.it.

Comment in
    Neurosci Insights. 2020 Jun 14;15:2633105520928068. doi: 
10.1177/2633105520928068.

Transdifferentiation of fibroblasts into induced neuronal cells (iNs) by the 
neuron-specific transcription factors Brn2, Myt1l, and Ascl1 is a paradigmatic 
example of inter-lineage conversion across epigenetically distant cells. Despite 
tremendous progress regarding the transcriptional hierarchy underlying 
transdifferentiation, the enablers of the concomitant epigenome resetting remain 
to be elucidated. Here, we investigated the role of KMT2A and KMT2B, two histone 
H3 lysine 4 methylases with cardinal roles in development, through individual 
and combined inactivation. We found that Kmt2b, whose human homolog's mutations 
cause dystonia, is selectively required for iN conversion through suppression 
of the alternative myocyte program and induction of neuronal maturation genes. 
The identification of KMT2B-vulnerable targets allowed us, in turn, to expose, 
in a cohort of 225 patients, 45 unique variants in 39 KMT2B targets, which 
represent promising candidates to dissect the molecular bases of dystonia.

Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

DOI: 10.1016/j.celrep.2018.09.067
PMCID: PMC6218204
PMID: 30355503 [Indexed for MEDLINE]